
Life Tech guides companies to the region’s research infrastructures
The Stockholm Life Tech project achieved its goal in the spring with a guide that makes it easier for more small and medium-sized companies to collaborate with the region’s research infrastructures. The guide has been billed as an important tool for strengthening life science entrepreneurship in the region.
Stockholm Life Tech was initiated as part of Region Stockholm’s vision to become one of the world’s top five life science regions. The three-year project was completed in the spring. The project had the twin goals of making the region’s research infrastructures more accessible to small and medium-sized enterprises (SMEs), and to strengthen the development of the region’s life science ecosystem to attract more companies.
“We’ve achieved both goals with results that were extremely well received and that made it possible for others to develop further,” says Nina Lahti, Project Manager for Stockholm Life Science, at Region Stockholm’s Research and Innovation Administration.
The project has contributed to national and regional life science strategies, Lahti says.
“We concentrated on three selected pilot projects where we saw a way forward to improve conditions for collaboration between small and medium-sized companies and research infrastructures.”
Guide for new collaborations
The three pilot projects were ANA Futura at Karolinska Institutet, Vecura at Karolinska Center for Cell Therapy, Karolinska University Hospital and A Working Lab (AWL) at Akademiska Hus. Based on these three trials, the project has developed a guide that provides support throughout the entire process from preparation, development to execution.
“With the help of the guide, we can approach SMEs more effectively with our services and establish collaborations with a clear, shared idea of given projects. We are now working on implementing the tool when new projects are set up, which will mean that our collaborations will be clearer and better,” says Pontus Blomberg
Operations Manager at Vecura.
One of the challenges for the project was the fact that the three infrastructures had different forms of ownership: state, regional, and as a state-owned company.
“This raised complicated legal issues in several areas of law, such as municipal law, procurement and confidentiality. We successfully established a model for close collaboration between different legal departments that resulted in well-functioning solutions that were then incorporated into the guide as a work tool,” says Lahti.
The project work provided new lessons for all participants, says Lahti.
“Our review provided increased knowledge about conditions and challenges that exist, especially in terms of managing research infrastructures. There are useful lessons to be learned when additional infrastructures are opened.”
The next step is for similar infrastructures to be opened in similar ways for companies. This work is being carried out by the Center for Innovative Medicine (CIMED), on Campus Flemingsberg among others.
Building vital co-operation bridges
In efforts to strengthen the development of the region’s life sciences ecosystem, collaboration has deepened between Flemingsberg Science and Karolinska Institutet Science Park.
“This aspect of the project has contributed to building important innovation bridges between the north and south of Stockholm. The setting up of AWL on Campus Flemingsberg also helped in this respect,” says Lahti.
AWL is a community and a meeting place focused on the life science sector that opened office and lab facilities in Flemingsberg in 2022.
“The Stockholm Life Tech project has been a contributing factor to our setting up in Campus Flemingsberg, and has created good conditions for continued collaboration between us and other research and innovation infrastructures in the area,” comments Åsa Johansson, responsible for the AWL concept at Akademiska Hus.
One step in strengthening the ecosystem has been the development of an online visualisation of actors in the local life sciences ecosystem. A first version has been published for Campus Flemingsberg and the development of another one for Campus Solna is underway.
“The visualisation of the ecosystem has been excellent because it’s something that not the company in particular has called for,” says Lahti.
Now Open: Flemingsberg Science Award STARTUP 2026
Do you have a business idea that can make a difference, locally or globally? Flemingsberg Science Award STARTUP is the competition for those who want to challenge their idea, gain valuable feedback from experienced experts, and take the first step toward building something real.
Campus Flemingsberg continues to grow – more students and strong collaboration in focus
Campus Flemingsberg remains one of Sweden’s most dynamic knowledge environments. Over the past year, the number of students has increased from 24,000 to approximately 27,000. The trend is clear: the campus’s broad academic profile continues to attract a growing number of students.
Limitless Potential: Winner of the Flemingsberg Science Award 2025
Young people in disadvantaged areas often face mental health challenges and a lack of support, which can lead to isolation and destructive choices. Limitless Potential, winner of the Flemingsberg Science Award IDEA 2025, has created a safe space where creativity and social entrepreneurship come together to support youth.
Alfa Laval strengthens Flemingsberg – establishes itself in a growing city of the future
In May 2025, Alfa Laval moved into its new office and innovation center, spanning approximately 20,000 square meters, together with around 700 employees. At the same time, the restaurant K-märkt opened, further expanding the range of services available in Flemingsberg. The Royal Swedish Opera and Dramaten, Alfa Laval, Restaurant Billmans, and K-märkt all represent important pieces of the puzzle in the development of Flemingsberg.
En nationell resurs för morgondagens behandlingar – nu är Karolinska ATMP Centrum invigt
Med ett tydligt budskap om framtidstro och ett kraftfullt samarbete invigdes Karolinska ATMP Centrum i Flemingsberg i slutet av augusti. Centret är ett samarbete mellan Karolinska Institutet och Karolinska Universitetssjukhuset, och kommer fungera som en nationell resurs för tillverkning av avancerade terapier (ATMP), där forskning, kliniska prövningar och behandlingar smidigt samverkar för att leverera banbrytande terapier till patienter.


